Tornoe joins Exagen Diagnostics

Wednesday, August 10, 2011 11:09 AM

Exagen Diagnostics has named Eric Tornoe its president and chief operating officer.

Tornoe has more than 20 years of healthcare industry experience. He previously worked for Pfizer, Wyeth and Bristol-Myers Squibb, quickly advancing his career in a number of senior management positions that dramatically expanded revenues.  

"Eric has a great track record in leading and directing teams to exceed corporate business and revenue objectives. He will play an instrumental role in the ongoing success of the company and its continued focus on personalized medicine,” said Scott Glenn, board chairman and CEO.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs